Moleculin Biotech announces plan for clinical trial drug production
Saturday, October 08, 2016
Moleculin Biotech Inc Has secured an agreement with Dermin Sp. Zo. O. ("Dermin") to utilize Dermin's supply of Annamycin for its upcoming clinical trial.
Agreement reached allows company to utilize Annamycin in upcoming clinical trials rather than having to produce new Annamycin for own use. Expanded clinical trials on Annamycin by first half of 2017.
Company plans to begin expanded clinical trials on Annamycin by first half of 2017.
Source : reuters.com
